Pathogenesis of HIV-1 Infection Within Bone Marrow Cells

References

• Spivak J L, Bender B S, Quinn T C. Hematological abnormalities in AIDS. Amer. J. Med. 1984; 77: 225–2128
   Web of Science ®Google Scholar
• Frontiera M, Myers A M. Peripheral blood and bone marrow abnormalities in AIDS. West. J. Med. 1987; 147: 157–160
   PubMedGoogle Scholar
• Fauci A S. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988; 239: 617–622
   PubMed Web of Science ®Google Scholar
• Zon L I, Arkin C, Groopman J E. Hematological manifestations of the human immunodeficiency virus. Brit. J. Hematol. 1987; 66: 251–256
   PubMed Web of Science ®Google Scholar
• Scadden D T, Zon L I, Groopman J E. Pathophysiology and management of HIV‐associated hematological disorders. Blood 1989; 74: 1455–1463
   PubMed Web of Science ®Google Scholar
• Coyle T E. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med. Clinics N. Amer. 1997; 81: 449–463
   PubMed Web of Science ®Google Scholar
• Ho D D, Pomerantz R J, Kaplan J C. Pathogenesis of infection with human immunodeficiency virus. N. Engl. J. Med. 1987; 317: 278–286
   PubMed Web of Science ®Google Scholar
• Chelucci C, Federico M, Guerriero R, Mattia G, Casella I, Pelosi E, Testa U, Mariani G, Hassan H J, Peschle C. Productive human immunodeficiency virus‐1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 1998; 91: 1225–1234
   PubMed Web of Science ®Google Scholar
• Weichold F F, Zella D, Barabitskaja O, Maciejewski J P, Dunn D E, Sloand E M, Young N S. Neither human immunodeficiency virus‐1 (HIV‐1) nor HIV‐2 infect most‐primitive human hematopoietic stem cells as assessed in long‐term bone marrow cultures. Blood 1998; 91: 907–915
   PubMed Web of Science ®Google Scholar
• Sben H, Cheng T, Preffer F I, Dombkowski D, Tomasson M H, Goland D E, Yang O, Hofmann W, Sodroski J G, Luster A D, Scadden D T. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite co‐receptor expression. J. Virol. 1999; 73: 728–737
   PubMed Web of Science ®Google Scholar
• Potts B J, Hoggan M, Lamperthy L, Spivak J. Replication of HIV‐1 and HIV‐1 in human bone marrow cultures. Virology 1992; 188: 840–849
   PubMed Web of Science ®Google Scholar
• Chelucci C, Hassan J H, Locardi C, Bulgarini D, Pelois E, Mariano G, Testa U, Federico M, Valtieri M, Peschle C. In vitro human immunodeficiency virus‐1 infection of purified hematopoietic progenitors in single cell culture. Blood 1995; 85: 1181–1187
   PubMed Web of Science ®Google Scholar
• Lunardi‐Iskandar Y, Georgoulias V, Bertoli A M, Augery‐Bourget Y, Ammar A, Vittecoq D, Rosenbaum W, Meyer P, Jasmin C. Impaired in vitro proliferation of hematopoietic precursors in HIV‐1‐infected subjects. Leuk. Res. 1989; 13: 573
   PubMed Web of Science ®Google Scholar
• Cen D, Zauli G, Szarnicki R, David B R. Effect of different human immunodeficiency virus type 1 (HIV‐1) isolates on long‐term bone marrow haemopoiesis. Br. J. Hematol. 1993; 85: 596–402
   PubMed Web of Science ®Google Scholar
• Neal T F, Holland H K, Baum C M, Villinger F, Ansari A A, Sari R, Wingard J R, Fleming W H. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus‐1. Blood 1995; 86: 1749–1756
   PubMed Web of Science ®Google Scholar
• DeLuca A, Teofili L, Antinori A, Iovino M S, Mencarini P, Visconti E, Tamburrini E, Leone G, Ortona L. Haematopoietic CD34+ progenitor cells are not infected by HIV‐1 in vivo but show impaired clonogenesis. Br. J. Haematol. 1993; 85: 20–24
   PubMed Web of Science ®Google Scholar
• Louache F, Henri A, Bettaieb A, Oksenhendler E, Raguin G, Tulliez M, Vainchenker W. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80: 2991–2999
   PubMed Web of Science ®Google Scholar
• Re M C, Zauli G, Gibellini D, Furlini G, Ramazzotti E, Monari P, Ranieri S, Capitani S, LaPlaca M. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 1993; 7: 1049–1055
   PubMed Web of Science ®Google Scholar
• Stanley S K, Kessler S W, Justement J S, Schnittman S M, Greenhouse J J, Brown C C, Musongela L, Musey K, Kapita B, Fauci A S. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J. Immunol. 1992; 149: 689–497
   PubMed Web of Science ®Google Scholar
• Davis B R, Schwartz D H, Marx J C, Johnson C E, Berry J M, Lyding J, Merigan T C, Zander A. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J. Virol. 1991; 65: 1985–1990
   PubMed Web of Science ®Google Scholar
• Vainchenker W, Louache F. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 1996; 88: 4568
   PubMed Web of Science ®Google Scholar
• Moses A, Nelson J, Bagby G C, Jr. The influence of human immunodeficiency virus‐1 on hematopoiesis. Blood 1998; 91: 1479–1495
   PubMed Web of Science ®Google Scholar
• Vignoli M, Stecca B, Furlini G, Re M C, Mantovani V, Zauli G, Visani G, Colangeli V, LaPlaca M. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV‐1‐infected patients. AIDS 1998; 12: 999–1005
   PubMed Web of Science ®Google Scholar
• Nielsen S D, Ersboll A K, Mathiesen L, Nielsen J O, Hansen J ‐E. HighIy active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus‐infected patients. J. Infect. Dis. 1998; 178: 1299–1305
   PubMed Web of Science ®Google Scholar
• Finzi D, Blankson J, Silicano J D, Margolick J B, Chadwick K, Pierson T, Smith K, Lisziewica J, Lori F, Flexner C, Quinn T C, Chaisson R E, Rosenberg E, Walker B, Gange S, Gallant J, Silicano R F. Latent infection of CD4+ T cells provide a mechanism for lifelong persistence of HIV‐1, even in patients on effective combination therapy. Nature Med 1999; 5: 512–517
   PubMed Web of Science ®Google Scholar
• Pomerantz R J. Residual HIV‐1 disease in the era of highly active antiretroviral therapy. Editorial. N. Engl. J. Med. 1999, In Press
   PubMed Web of Science ®Google Scholar
• Zhang H, Dornadula G, Beumont M, Livornese L, Van Uitert B, Henning K, Pomerantz R J. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 1998; 339: 1803–9
   PubMed Web of Science ®Google Scholar
• Gill V, Shattock J, Scopes J, Hayes P, Freedman A R, Griffin D E, Gordon‐Smith E C, Gibson F M. Human immunodeficiency virus infection impairs hematopoiesis in long‐term bone marrow cultures: Non‐reversal by nucleoside analogues. J. Infect. Dis. 1997; 176: 1510–6
   PubMed Web of Science ®Google Scholar
• Sloand E M, Young N S, Sato T, Kumar P, Kim S, Weichold F F, Maciejewski J P. Secondary colony formation after long‐term bone marrow culture using peripheral blood and bone marrow of HIV‐1‐infected patients. AIDS 1997; 11: 1547–1553
   PubMed Web of Science ®Google Scholar
• Lunardi‐Iskander Y, Georgoulias V, Bertli A M, Augery‐Bourgef Y, Ammar A, Vittecoqu D, Rosenbaum W, Meyer P, Jasmin C. Impaired in vitro proliferation of hematopoietic precursors in HIV‐1‐infected subjects. Leuk. Res. 1989; 13573
   Web of Science ®Google Scholar
• Zhao S ‐F, Li W, Domadula G, Dicker D, Hoxie J, Peiper S C, Pomerantz R J, Duan L ‐X. Chemokine receptors and the molecular basis for HIV‐1 entry into peripheral hematopoietic stem cells. J. Infect. Dis. 1998; 178: 1623–1634
   PubMed Web of Science ®Google Scholar
• Zauli G, Furlini G, Vitale M, Re M C, Gibellini D, Zamai L, Visano G, Borgatti P, Capitano S, LaPlaca M. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high affinity receptor for human immunodeficiency virus type 1. Blood 1994; 84: 1896–1905
   PubMed Web of Science ®Google Scholar
• Koka P S, Fraser J K, Bryson Y, Bristol G C, Aldrovandi G M, Daar E S, Zack J A. Human immunodeficiency virus inhibits multi‐lineage hematopoiesis in vivo. J. Virol. 1998; 72: 5121–5127
   PubMed Web of Science ®Google Scholar
• Jenkins M, Hanley M B, Moreno M B, Wieder E, McCune J M. Human immunodeficiency virus‐1 infection interrupts thymopoiesis and multi‐lineage hematopoiesis in viva. Blood 1998; 91: 2672–2678
   PubMed Web of Science ®Google Scholar
• Schwartz G N, Kessler S W, Rothwell S W, Burrell L M, Reid T J, Meltzer M S, Wright D G. Inhibitory effects of HIV‐1‐infected stromal cell layers on the production of myeloid progenitor cells in human long‐term bone marrow culture. Exp. Hematol. 1995; 22: 1288
   Web of Science ®Google Scholar
• Moses A V, Williams S, Heneveld M L, Strussenberg J, Rarick M, Loveless M, Bagby G, Nelson J A. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 1996; 87: 919–925
   PubMed Web of Science ®Google Scholar
• Mosca J D, Kaushal S, Gartner S, Kessler S W, LaRussa V F, Terwilliger E F, Kim J H, Carroll R G, Hall E R, Perrera Yu LP, Zhipeng Ritchey DW, Xu J, St. Louis D C, Mayers D L. Characterization of a human stromal cell line supporting hematopoietic progenitor cell proliferation: Effect of HIV expression. J. Biomed. Sci. 1995; 2: 330–342
   PubMedGoogle Scholar
• Scadden D T, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, Lim B, Groopman J E. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990; 76: 317–322
   PubMed Web of Science ®Google Scholar
• Canque B, Maradin A, Rosenzwaig M, Louache F, Vainchenker W, Gluckman J C. Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 1995; 208: 779–83
   PubMed Web of Science ®Google Scholar
• Sun N CJ, Shapshak P, Lachant N A, Hsu M ‐Y, Sieger L, Schmid P, Geall G, Imagawa D T. Bone marrow examination in patients with AIDS and AIDS‐related complex (ARC). Amer. J. Clin. Pathol. 1989; 92: 589–594
   PubMed Web of Science ®Google Scholar
• Weiser B, Burger H, Campbell P, Donelan S, Mladenovic J. HIV type 1 RNA expression in bone marrows of patients with a spectrum of disease. AIDS Res. and Human Retroviruses 1996; 12: 1551–1559
   PubMed Web of Science ®Google Scholar
• Kitano K, Abboud C N, Ryan D H, Quan S G, Baldwin G C, Golde D W. Macrophage‐active colony‐stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 1991; 77: 1699–1705
   PubMed Web of Science ®Google Scholar
• Gill V, Shattock R J, Freedman A R, et al. Macrophages are the major target cell for HIV infection in long‐term bone marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV‐1. Br. J. Hematol. 1996; 93: 30–7
   PubMed Web of Science ®Google Scholar
• Sugiura K, Oyaizu N, Pahway R, Kalyanaraman V S, Pahwa S. Effect of human immunodeficiency virus‐1 envelope glycoprotein on in vivo hematopoiesis of umbilical cord blood. Blood 1992; 80: 1463–1469
   PubMed Web of Science ®Google Scholar
• Rameshwar P, Denny T N, Gascon P. Enhanced HIV‐1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. J. Immunol. 1996; 157: 4244–4250
   PubMed Web of Science ®Google Scholar
• Adams G B, Pym A S, Poznansky M C, McClure M O, Weber J N. The in vivo effects of combination antiretroviral drug therapy on peripheral blood CD34+ cell colony‐forming units from HIV type 1 infected patients. AIDS Res and Human Retroviruses 1999; 15: 551–559
   PubMed Web of Science ®Google Scholar
• de Monye C, Karcher D S, Boelaert J R, Gordeuk V R. Bone marrow macrophage iron grade and survival of HIV‐seropositive patients. AIDS 1999; 13: 375–380
   PubMed Web of Science ®Google Scholar
• Voulgaropoulou F, Tan B, Soares M, Hahn B, Rat‐ner L. Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia. J. Virol. 1999; 73: 3497–3504
   PubMed Web of Science ®Google Scholar
• Slobod K S, Bennett T A, Freiden P J, Kechli Am, Howlett N, Flynn P M, Head D R, Srivastava D K, Boyett J M, Brenner M K, Garcia J V. Mobilization of CD34+ progenitor cells by granulocyte colony‐stimulating factor in human immunodeficiency virus type 1‐infected adults. Blood 1996; 88: 3329–3335
   PubMed Web of Science ®Google Scholar
• Nielsen S D, Afzelius P, Dam‐larsen S, et al. Effect of granulocyte colony‐stimulating factor (G‐CSF) in human immunodeficieny virus infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G‐CSF a candidate for use in gene therapy or to support antiretroviral therapy. J. Inf. Dis. 1998; 177: 1733–6
   PubMed Web of Science ®Google Scholar
• Schooley R T, Mladenovic J, Sevin A, Chiu S, Miles S A, Pomerantz R J, Campbell T B, Bell D, Ambruso D, Wong R, Landay A, Coombs R W, Fox L, Kamoun M, Jacovini J, ACTG 285 Study Team. A pilot study of CD34+ stem cell mobilization and harvesting from the peripheral blood of persons with HIV‐1 infection: reduced mobilization in advanced disease. J. Inf. Dis.
   Google Scholar
• Cambell T, Sevin A, Coombs R W, Peterson G C, Rosandich M, Kuritzkes D R, Mladenovic J, Landay A, Wong R, Ambruso D, Miles S, Pomerantz R J, Schooley R T, ACTG 285 Study Team. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hematopoietic progenitor cells. Blood
   PubMed Web of Science ®Google Scholar
• Scadden D T, Pickus Hammer SC, Stretcher B, Bresnahan J, Gere J, McGrath J, Agosti J M. Lack of in vivo effect of granulocyte‐macrophage colony‐stimulating factor on human immunodeficiency virus type 1. AIDS Res and Human Retroviruses 1996; 12: 1151–1159
   PubMed Web of Science ®Google Scholar
• Groopman J E, Mitsuyasu R T, DeLeo M J, Oette D H, Golde D W. Effect of recombinant human granulocyte‐macrophage colony‐stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N. Eng. J. Med. 1997; 317: 593–598
   Web of Science ®Google Scholar
• Mondal D, Agrawal K C. Effect of HIV type 1 Tat protein on butyric acid‐induced differentiation in a hematopoietic progenitor cell line. AIDS Res and Human Retro‐viruses 1996; 12: 1529–1536
   PubMed Web of Science ®Google Scholar
• Frazier A LB, Garcia J V. Retrovirus‐mediated transfer and long‐term expression of HIV type 1 tat gene in murine hematopoietic tissues. AIDS Res and Human Retroviruses 1994; 10: 1517–1524
   PubMed Web of Science ®Google Scholar
• Calenda V, Graber P, Delamarter J F, Chermann J C. Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells. Eur. J. Hematol. 1994; 52: 103–107
   PubMed Web of Science ®Google Scholar
• Zauli G, Vitale M, Re M C, Furlini G, Zamai L, Falcieri E, Bibellini D, Visani G, Davis B R, Capitano S, LaPlaca M. In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor dependent W‐1 hematopoietic cell‐lines. Blood 1994; 83: 167–175
   PubMed Web of Science ®Google Scholar
• Re M C, Furlini G, ZauIi G, LaPlaca M. Human immunodeficiency virus type 1 (HIV‐1) and human hematopoietic progenitor cells. Arch. Virol. 1994; 137: 1–23
   PubMed Web of Science ®Google Scholar
• Zauli G, Vitale M, Gibellini, Capitano S. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1. J. Exp. Med. 1996; 183: 99–108
   PubMed Web of Science ®Google Scholar
• Zauli G, Re M C, Visani G, Furlini G, Mazza P, Vignoli M, LaPlaca M. Evidence for a human immunodeficiency virus type 1‐mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J. Infect. Dis. 1992; 166: 710–6
   PubMed Web of Science ®Google Scholar
• Kaushal S, LaRussa V R, Gartner S, Kessler S, Perfetto S, Yu Z, Ritchey D W, Xu J, Perera P, Kim J, Reid T, Mayers D L, St Louis D, Mosca J D. Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitru. Blood 1996; 88: 130–137
   PubMed Web of Science ®Google Scholar
• Wiley E L, Nightingale S D. Opportunistic events and p17 expression in the bone marrow of human immunodeficiency virus‐infected patients. J. Infect. Dis. 1994; 169: 617–20
   PubMed Web of Science ®Google Scholar
• Geissler R G, Ganser A, Ottmann O G, Gute P, Morawetz A, Guba P, Helm E B, Hoelzer D. In vitro improvement of bone marrow‐derived hematopoietic colony formation in HIV‐positive patients by alpha‐D‐tocopherol and erythropoietin. Eur. J. Hematol. 1994; 53: 201–206
   PubMed Web of Science ®Google Scholar
• Steinberg H N, Crumpacker C S, Chatis P A. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J. Virol. 1991; 65: 1765–1769
   PubMed Web of Science ®Google Scholar
• Stella C C, Ganser A, Hoelzer D. Defective in vitro growth of the hematopoietic progenitor cells in the acquired immunodeficiency syndrome. J. Clin. Invest. 1987; 80: 286–293
   PubMed Web of Science ®Google Scholar
• Donahue R E, Johnson M M, Zon L I, Clark S C, Groopman J E. Suppression of in vitru haematopoiesis following human immunodeficiency virus infection. Nature 1987; 326: 200–203
   PubMed Web of Science ®Google Scholar
• Hillyer C D, Lackey D A, Villinger F, Winton E F, McClure H M, Ansari A A. CD34+ and CFU‐Gm progenitors are significantly decreased in SIVsmm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction. Am. J. Hematol. 1993; 43: 274
   PubMed Web of Science ®Google Scholar
• Kinniburgh D, Russell N H. Comparative study of CD34 positive cells and subpopulations in human umbilical cord blood and bone marrow. Bone Marrow Transplantation 1993; 12: 489–494
   PubMed Web of Science ®Google Scholar
• Steinberg H N, Anderson J, Crumpacker C S, Chatis P A. HIV infection of the BS‐1 human stroma cells line: effect on murine hematopoiesis. Virology 1993; 193: 524
   PubMed Web of Science ®Google Scholar
• Bagnara G P, Zauli G, Giovannini M, Re M C, Furlini G, LaPlaca M. Early loss of circulating hematopoietic progenitors in HIV‐1‐infected subjects. Exp. Hematol. 1990; 18: 426
   PubMed Web of Science ®Google Scholar
• Marandin A, Canque B, Coulombel L, Gluckman J C, Vainchenker W, Louache F. In vitro infection of bone marrow adherent cells by human immunodeficiency virus type 1 (HIV‐1) does not alter their ability to support haematopoiesis. Virology 1995; 213: 245–248
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Ganser A. Gamma delta‐T cell receptor positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1‐infected patients. AIDS Res Human Retroviruses 1996; 12: 577
   PubMed Web of Science ®Google Scholar
• Bahner I, Kearns K, Coutinho S, Leonard E H, Kohn D B. Infection of human marrow stroma by human immunodeficiency virus‐1 (HIV‐1) is both required and sufficient for HIV‐1‐induced hematopoietic suppression in virro: demonstration by gene modification of primary human stroma. Blood 1997; 90: 1781
   Web of Science ®Google Scholar
• Esser R, Glienke W, Von Briesen H, Rubsamen‐Waigmann H, Andreesen R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 1996; 88: 3474
   PubMed Web of Science ®Google Scholar
• Maciejewski J P, Weichold F F, Young N S. HIV‐1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF‐alpha. J. Immunol. 1994; 163: 4303
   Google Scholar
• Zauli G, Davis B R, Re M C, Visani G, Furlini G, LaPlaca M. Tat protein stimulated production of transforming growth factor β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus‐1‐induced hematopoietic suppression. Blood, 80: 3036, 2992
   Google Scholar
• Maradin A, Katz A, Oksenhendler E, et al. Loss of primitive progenitors in patients with human immunodeficiency virus infection. Blood 1996; 88: 4568–78
   PubMed Web of Science ®Google Scholar
• Kaczmarski R S, Davison F, Blair E, Sutherland S, Moxhan J, McManus T, Mufti G J. Detection of HIV in haematopoietic progenitors. Br. J. Haematol. 1992; 82: 764–769
   PubMed Web of Science ®Google Scholar
• Folks T M, Kessler S W, Orenstein J M, Justement J S, Jaffe E S, Fauci A S. Infection and replication of HIV‐1 in purified progenitor cells of normal human bone marrow. Science 1988; 242: 919–922
   PubMed Web of Science ®Google Scholar
• Zauli G, Vitale M, Gibellini D, Capitini S. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J. Exp. Med. 1996; 183: 99
   PubMed Web of Science ®Google Scholar
• Alllalio G, North M, Means R T, Jr. Inhibition of marrow CFU‐E colony formation from human immunodeficiency virus infected patients by β‐ and gamma interferon. Amer. J. Hematol. 1996; 53: 118
   PubMed Web of Science ®Google Scholar
• Emerman M. HIV‐1, Vpr and the cell cycle. Curr. Biol. 1996; 6: 1096–1103
   PubMed Web of Science ®Google Scholar
• Vodicka M A, Koepp D M, Silver P A, Emerman M. HIV‐1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes. & Develop. 1998; 12: 175–185
   PubMed Web of Science ®Google Scholar
• Connor R I, Chen B K, Choe S, Landau N R. Vpr is required for efficient replication of human immunodeficiency virus type 1 in mononuclear phagocytes. Virology 1995; 206: 935–944
   PubMed Web of Science ®Google Scholar
• Heinzinger N, Bukrinsky M, Haggerty S, Ragland A, KewalRamani V, Lee M, Gendelman H, Ratner L, Stevenson M, Emerman M. The HIV‐I Vpr protein influences nuclear targeting of viral nucleic acids in non‐dividing cells. Proc. Natl. Acad. Sci. USA. 1994; 91: 7311–7315
   PubMed Web of Science ®Google Scholar
• Gallay P, Stitt V, Mundy C, Oettinger M, Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 1996; 70: 1027–1032
   PubMed Web of Science ®Google Scholar
• Rey F, BouHamdan M, Navarro J ‐M, Agostini I, Wil‐letts K, Bouyac M, Tamalet C, Spire B, Vigne R, Sire J. A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. J. Gen. Virol. 1998; 79: 1083–1087
   PubMed Web of Science ®Google Scholar
• Vodicka M A, Koepp D M, Silver P A, Emerman M. HIV‐1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes. & Develop. 1998; 12: 175–185
   PubMed Web of Science ®Google Scholar
• Fouchier R AM, Meyer B E, Simon J HM, Fischer U, Albright A V, Gonzalez‐Scarano F, Malim M H. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 1998; 72: 6004–5013
   PubMed Web of Science ®Google Scholar
• Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M. Viral protein R regulates docking of the HIV‐1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 1998; 273: 13347–13352
   PubMed Web of Science ®Google Scholar
• Re E, Braaaten D, Franke E K, Luban J. Human immunodeficiency virus type 1 arrests the cell cycle in G2 by inhibiting the activation of p334cdc2‐cyclin B. J. Virol. 1995; 69: 6859–6564
   PubMed Web of Science ®Google Scholar
• Goh W ‐C, Roger M E, Kinsey C M, Michael S F, Fultz P N, Nowak M A, Hahn B H, Emerman M. HIV‐1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nature Med. 1998; 4: 65–71
   PubMed Web of Science ®Google Scholar
• Jowett J BM, Plannelles V, Poon B, Shah N P, Chen M ‐L, Chen I SY. The human immunodeficiency virus type 1 Vpr gene arrests infected T cells in the G2 M phase of the cell cycle. J. Virol. 1995; 69: 6304–6313
   PubMed Web of Science ®Google Scholar
• He J, Choe S, Walker R, DiMarzio P, Morgan D O, Landau N R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995; 69: 6705–6711
   PubMed Web of Science ®Google Scholar
• Planelles V, Bachelerie F, Jowett J BM, Haislip A, Xie Y, Banooni P, Masuda T, Chen I SY. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for Vpr. J. Virol. 1995; 69: 5883–5889
   PubMed Web of Science ®Google Scholar
• Roger M E, Wu L I, Emerman M. The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection. J. Virol. 1995; 69: 882–88
   PubMed Web of Science ®Google Scholar
• Bartz S R, Rogel M E, Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 1996; 70: 2324–2331
   PubMed Web of Science ®Google Scholar
• Poon B, Jowett J BM, Stewart S A, Armstrong R W, Rishton G M, Chen I SY. Human immunodeficiency virus type 1 Vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J. Virol. 1997; 71: 3961–3971
   PubMed Web of Science ®Google Scholar
• Levy D N, Fernandes L S, Williams W V, Weiner D B. Induction of cell differentiation by human immunodeficiency virus 1 Vpr. Cell 1993; 72: 541–550
   PubMed Web of Science ®Google Scholar
• Yao X ‐J, Mouland A J, Subbramanian R A, Forget J, Rougeau N, Bergeron D, Cohen E A. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1 infected dividing Jurkat T cells. J. Virol. 1998; 72: 4686–4693
   PubMed Web of Science ®Google Scholar
• Yao X ‐J, Subramanian R A, Rougeau N, Boisvert F, Bergeron D, Cohen E A. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N‐terminal alpha‐helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 1995; 69: 7032–7044
   PubMed Web of Science ®Google Scholar
• Kondo E, Mammano F, Cohen E A, Gottlinger H G. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 1995; 69: 2759–2764
   PubMed Web of Science ®Google Scholar
• Paxton W, Connor R I, Landau N R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 1993; 67: 7229–7237
   PubMed Web of Science ®Google Scholar
• Felzien L K, Woffendin C, Hottiger M O, Subbramanian R A, Cohen E A, Nabel G J. HIV transcriptional activation by the accessory protein, Vpr, is mediated by the p300 co‐activator. Proc. Natl. Acad. Sci. USA. 1998; 95: 5281–5286
   PubMed Web of Science ®Google Scholar
• Hrimechi M, Yao X ‐J, Bachand F, Rougeau N, Cohen E A. Human immunodeficiency virus type 1 (HIV‐1) Vpr functions as a immediate early protein during HIV‐1 infection. J. Virol. 1999; 73: 4101–4109
   PubMed Web of Science ®Google Scholar
• Levy D N, Refaeli Y, Weiner D B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 1995; 69: 1243–1252
   PubMed Web of Science ®Google Scholar
• Levy D N, Refaeli Y, MacGregor R R, Weiner D B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 1994; 91: 10873–10877
   PubMed Web of Science ®Google Scholar
• Refaeli Y, Levy D N, Weiner D B. The glucocorticoid receptor type II complex is a target of the HIV‐1 Vpr gene product. Proc. Natl. Acad. Sci. USA. 1995; 92: 3621–3625
   PubMed Web of Science ®Google Scholar
• Bouhamdan M, Benichou S, Rey F, Navmo J ‐M, Agostini I, Spire B, Camonis J, Slupphaug G, Vigne R, Benarous R, Sire J. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosy‐lase DNA repair enzyme. J. Virol. 1996; 70: 697–704
   PubMed Web of Science ®Google Scholar
• Gragerov A, Kino T, Ilyin‐Gragerova G, Chrousos G P, Pavlakis G N. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. Virology 1998; 245: 323–330
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lu Y, Ratner L. Arginine residues in the C‐terminus of HIV‐1 Vpr are important for nuclear localization and cell cycle arrest. Virology 1998; 242: 414–424
   PubMed Web of Science ®Google Scholar
• Mahalingam S, Khan S A, Jabbar M A, Monken C E, Collman R G, Srinivasan A. Identification of residues in the N‐terminal acidic domain of HIV‐1 Vpr essential for virion incorporation. Virology 1995; 207: 297–302
   PubMed Web of Science ®Google Scholar
• DiMarzio P, Choe S, Ebright M, Knoblauch R, Landau N R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 1995; 69: 7909–7916
   PubMed Web of Science ®Google Scholar
• Macreadie I G, Castelli L A, Hewish D R, Kirkpatrick A, Ward A C, Azad A A. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motif causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA. 1995; 92: 2770–2774
   PubMed Web of Science ®Google Scholar
• Mahalingam S, Patel M, Collman R G, Srinivasan A. The carboxy‐terminal domain is essential for stability and not for virion incorporation of HIV‐1 Vpr into virus particles. Virology 1995; 214: 647–452
   PubMed Web of Science ®Google Scholar
• Mahalingam S, Collman R G, Patel M, Monken C E, Srinivasan A. Role of the conserved dipeptide Gly75 and Cys76 on HIV‐1 Vpr function. Virology 1995; 210: 495–500
   PubMed Web of Science ®Google Scholar
• Nie Z, Bergeron D, Subbramanian R A, Yao X ‐J, Checroune F, Rougeau N, Cohen E A. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth‐arrested cells. J. Virol. 1998; 72: 4104–4115
   PubMed Web of Science ®Google Scholar
• Poon B, Grovit‐Ferbas K, Stewart S A, Chen I SY. Cell cycle arrest by Vpr in HIV‐1 virions and insensitivity to antiretroviral agents. Science 1998; 281: 266–270
   PubMed Web of Science ®Google Scholar
• Zhao Y, Cao J, O'Gorman M RG, Yu M, Yogev R. Effect of human immunodeficiency virus type 1 protein R (Vpr) gene expression on basic cellular function of fission yeast schizosaccharomyces pombe. J. Virol. 1996; 70: 5821–5826
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yu M, Chen M, Elder R T, Yamamoto A, Cao J. Pleiotropic effects of HIV‐1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virology 1998; 246: 266–276
   PubMed Web of Science ®Google Scholar
• Stewart S A, Poon B, Jowett J BM, Chen I SY. Human immunodeficiency virus Vpr induces apoptosis following cell cycle arrest. J. Virol. 1997; 71: 5579–5592
   PubMed Web of Science ®Google Scholar
• Conti L, Rainaldi G, Matarrese P, Varano B, Rivabene R, Columba S, Sato A, Belardelli F, Malorni W, Gessani S. The HIV‐1 Vpr protein acts as a negative regulatory of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS. J. Exp. Med. 1998; 187: 403–413
   PubMed Web of Science ®Google Scholar
• Ayyavoo V, Mahboubi A, Mahalingam S, Ramdingam R, Kudchodkax S, Williams W V, Green D R, Weiner D B. HIV‐1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kB. Nature Med. 1997; 3: 1117–1123
   PubMed Web of Science ®Google Scholar
• Lamb R A, Pinto L H. Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life‐cycles?. Virology 1997; 229: 1–11
   PubMed Web of Science ®Google Scholar
• Piller S C, Ewart G D, Premkumar A, Cox G B, Gage P W. Vpr protein of human immunodeficiency virus type 1 forms cation‐selective channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA. 1996; 93: 111–115
   PubMed Web of Science ®Google Scholar
• Piller S C, Ewart G D, Jans D A, Gage P W, Cox G B. The amino‐terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J. Virol. 1999; 73: 4230–4238
   PubMed Web of Science ®Google Scholar
• Wu X, Liu H, Xiao H, Kim J, Seshaiah P, Natsoulis G, Boeke J D, Hahn B H, Kappes J C. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J. Virol. 1995; 69: 3389–3398
   Google Scholar
• Fletcher T M, Soares M A, McPhearson S, Hui H, Wiskerchen M A, Muesing M A, Shaw G M, Leavitt A D, Boeke J D, Hahn B H. Complementation of inte‐grase function in HIV‐I virions. EMBO J. 1997; 16: 5123–5138
   PubMed Web of Science ®Google Scholar
• Wu X, Liu H, Xiao H, Conway J A, Hunter E, Kappes J C. Functional R. T. and IN incorporated into HIV‐I particles independently of the GagPol precursor protein. EMBO J. 1997; 16: 5113–5122
   PubMed Web of Science ®Google Scholar
• Wu X, Liu H, Xiao H, Conway J A, Kappes J C. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx‐protease‐mutant fusion protein into viral particles. J. Viol. 1996; 3378–3384
   PubMed Web of Science ®Google Scholar
• Duan L ‐X, Oakes J, Ferraro A, Bagasra O, Pomerantz R J. Tat and rev affect replication of human immunodeficiency virus type 1 in various cells. Viology 1994; 199: 474
   PubMed Web of Science ®Google Scholar
• Pereira R, Halford K W, O'Hara M, Leeper D B, Sokolov B P, Pollard M D, Bagasra O, Prockop D J. Cultured adherent cells from marrow can serve as long‐lasting precursor cells for bone, cartilage and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 1995; 92: 4857
   PubMed Web of Science ®Google Scholar
• Tomida M. Mononuclear Phagocytes: Physiology and Pathology, R T Dean, W Jessup. Elsevier, Amsterdam 1985; 243
   Google Scholar
• Turpin J, Lopez‐Berestein G. Mononuclear Phagocytes. Cell Biology, G Lopez‐Berestein, J Klostergaard. CRC Press, Boca Raton 1993; 71
   Google Scholar
• Kulkosky J, Laptev A, Shetty S, Srinivasan A, BouHamdan M, Prockop D J, Pomerantz R J. HIV‐1 Vpr alters bone marrow cell function. Blood 1999; 93: 1906–1915
   PubMed Web of Science ®Google Scholar
• Cen D, Zauli G, Szarnicki R, Davis B R. Effect of different human immunodeficiency virus type‐1 (HIV‐1) isolates on long‐term bone marrow haemopoiesis. Brit. J. of Haemat., 85: 596–602
   PubMed Web of Science ®Google Scholar
• Harbol A W, Liesveld J L, Simpsom‐Haidaris J, Abboud C N. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev. 1994; 8: 241
   PubMed Web of Science ®Google Scholar
• Gowda S D, Stein B S, Mohagheghpour N, Benike C J, Engleman E G. Evidence that T cell activation is required for HIV‐1 entry in CD4+ lymphocytes. J. Immunol. 1989; 142: 773
   PubMed Web of Science ®Google Scholar
• Connor R I, Chen B K, Choe S, Landau N R. Vpr is required for efficient replication of human immunodeficiency virus type‐1 in mononuclear phagocytes. Virology 1995; 206: 935
   PubMed Web of Science ®Google Scholar
• Hattori N, Michaels F, Fargnoli K, Marcon L, Gallo R C, Franchini G. The human immunodeficiency virus type 2 Vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA 1990; 87: 8080
   PubMed Web of Science ®Google Scholar
• Campbell B J, Hirsch V. Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes. J. Virol. 1997; 71: 5593
   PubMed Web of Science ®Google Scholar